BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24494746)

  • 1. Comparison of prednisolone acetate and loteprednol etabonate for the treatment of benzalkonium chloride-induced dry eye syndrome in rats.
    Beyazyıldız E; Acar U; Beyazyıldız Ö; Pınarlı FA; Albayrak A; Uğurlu N; Tiryaki M; Delibaşi T
    J Ocul Pharmacol Ther; 2014 May; 30(4):306-12. PubMed ID: 24494746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
    Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
    Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
    He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
    Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.
    Sheppard JD; Donnenfeld ED; Holland EJ; Slonim CB; Solomon R; Solomon KD; McDonald MB; Perry HD; Lane SS; Pflugfelder SC; Samudre SS
    Eye Contact Lens; 2014 Sep; 40(5):289-96. PubMed ID: 25083776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.
    Zhang Z; Yang WZ; Zhu ZZ; Hu QQ; Chen YF; He H; Chen YX; Liu ZG
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2963-74. PubMed ID: 24722696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the treatment of dry eye with Loteprednol Etabonate].
    Wan PX; Wang XR; Song YY; Li ZY; Duan HC; Zhang W; Liu Z; Wang ZC
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):142-7. PubMed ID: 22490950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse dry eye model induced by topical administration of benzalkonium chloride.
    Lin Z; Liu X; Zhou T; Wang Y; Bai L; He H; Liu Z
    Mol Vis; 2011 Jan; 17():257-64. PubMed ID: 21283525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.
    Li C; Song Y; Luan S; Wan P; Li N; Tang J; Han Y; Xiong C; Wang Z
    PLoS One; 2012; 7(3):e33688. PubMed ID: 22438984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS; Holland EJ
    J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
    Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
    Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.
    Sheppard JD; Scoper SV; Samudre S
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):23-7. PubMed ID: 21133792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
    Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
    Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ophthalmic loteprednol etabonate and prednisolone acetate effects on adrenocortical response to ACTH in dogs.
    Kline KE; Walton SA; Specht AJ; Santoro D; Watson TJ; Eide ML; Opgenorth TA; Plummer CE
    Vet Ophthalmol; 2022 Nov; 25(6):468-475. PubMed ID: 35913421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model.
    Kim KA; Hyun LC; Jung SH; Yang SJ
    Mol Vis; 2016; 22():284-93. PubMed ID: 27110091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
    Vittitow JL; Williams JI
    J Cataract Refract Surg; 2020 Aug; 46(8):1092-1101. PubMed ID: 32352250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.
    Liu X; Yu FF; Zhong YM; Guo XX; Mao Z
    Chin Med J (Engl); 2015 Sep; 128(18):2444-9. PubMed ID: 26365960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
    Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
    Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
    Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
    Price MO; Feng MT; Scanameo A; Price FW
    Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.